
|Articles|August 26, 2022
News Roundup: August 22 to August 26
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
FDA EUA Sought by Pfizer-BioNTech for Omicron Booster
Pfizer-BioNTech hopes booster can be available for use this fall.
Plan for Monkeypox Vaccine Production Released by Federal Officials
Domestic production to begin at Michigan-based pharmaceutical maker.
Immune Health Supplements May Not Be What They Seem
Consumers are purchasing dietary supplements that support or boost the immune system like never before.
FDA Expands Novavax EUA for Use in Adolescents Aged 12 to 17
The vaccine was previously authorized under an EUA for adults aged 18 and older.
Using NSAIDs Tied to Risk of Heart Failure in Patients with Type 2 Diabetes
Used to treat a variety of concerns and found in many medicine cabinets, new research indicates that nonsteroidal anti-inflammatory drugs may pose a risk to patients with type 2 diabetes.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage
2
Wegovy Pill Receives FDA Approval as First Oral GLP-1 for Weight-Loss
3
CoronaVac Improves Outcomes of COVID-19 for Patients With Schizophrenia
4
Women’s Health: Top Stories of 2025
5
















































































































